Literature DB >> 16389449

The multifunctional roles of the four-and-a-half-LIM only protein FHL2.

M Johannessen1, S Møller, T Hansen, U Moens, M Van Ghelue.   

Abstract

Numerous cellular processes require the concerted action of multiple proteins that assemble in functional complexes. Protein-protein interaction domains allow specific proteins to combine with certain partners. Specificity of protein-protein association can be obtained by an interaction code predicted by conserved amino acid sequences. One of the protein-protein interaction motifs is the LIM domain, a conserved cysteine-rich module present in more than 100 different human proteins. The human four-and-a-half-LIM-only protein family consists of the members FHL1, FHL2, FHL3, FHL4 and ACT. They are expressed in a cell- and tissue-specific manner and participate in various cellular processes, including regulation of cell survival, transcription and signal transduction. Here, we review the current knowledge of the best-studied member of this family, FHL2. We describe the transcription regulation, the expression profile, the interaction partners, the subcellular localization, the biological functions and discuss the possible involvement of FHL2 in human diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16389449     DOI: 10.1007/s00018-005-5438-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  98 in total

1.  FHL2 protein is a novel co-repressor of nuclear receptor Nur77.

Authors:  Kondababu Kurakula; Erik van der Wal; Dirk Geerts; Claudia M van Tiel; Carlie J M de Vries
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

Review 2.  EpCAM and its potential role in tumor-initiating cells.

Authors:  Sannia Imrich; Matthias Hachmeister; Olivier Gires
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

3.  Site-specific proteolysis of the transcriptional coactivator HCF-1 can regulate its interaction with protein cofactors.

Authors:  Jodi L Vogel; Thomas M Kristie
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-19       Impact factor: 11.205

4.  Nuclear signalling by tumour-associated antigen EpCAM.

Authors:  Dorothea Maetzel; Sabine Denzel; Brigitte Mack; Martin Canis; Philip Went; Michael Benk; Cuong Kieu; Peer Papior; Patrick A Baeuerle; Markus Munz; Olivier Gires
Journal:  Nat Cell Biol       Date:  2009-01-11       Impact factor: 28.824

5.  Weighted gene coexpression network analysis of human left atrial tissue identifies gene modules associated with atrial fibrillation.

Authors:  Nicholas Tan; Mina K Chung; Jonathan D Smith; Jeffrey Hsu; David Serre; David W Newton; Laurie Castel; Edward Soltesz; Gosta Pettersson; A Marc Gillinov; David R Van Wagoner; John Barnard
Journal:  Circ Cardiovasc Genet       Date:  2013-07-17

6.  Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites.

Authors:  Ines Florath; Katja Butterbach; Heiko Müller; Melanie Bewerunge-Hudler; Hermann Brenner
Journal:  Hum Mol Genet       Date:  2013-10-26       Impact factor: 6.150

Review 7.  Molecular genetics and pathogenesis of cardiomyopathy.

Authors:  Akinori Kimura
Journal:  J Hum Genet       Date:  2015-07-16       Impact factor: 3.172

8.  RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3.

Authors:  Wei Han; Zhongshuai Xin; Zhiqiang Zhao; Wen Bao; Xihua Lin; Bin Yin; Jizong Zhao; Jiangang Yuan; Boqin Qiang; Xiaozhong Peng
Journal:  J Clin Invest       Date:  2013-04-15       Impact factor: 14.808

9.  The cell migration protein Grb7 associates with transcriptional regulator FHL2 in a Grb7 phosphorylation-dependent manner.

Authors:  Sharareh Siamakpour-Reihani; Haroula J Argiros; Lori J Wilmeth; L Lowell Haas; Tabitha A Peterson; Dennis L Johnson; Charles Brad Shuster; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2009 Jan-Feb       Impact factor: 2.137

10.  The four and a half LIM family members are novel interactants of the human T-cell leukemia virus type 1 Tax oncoprotein.

Authors:  Áine McCabe; Kenichi Hashimoto; William W Hall; Noreen Sheehy
Journal:  J Virol       Date:  2013-04-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.